| Literature DB >> 31708660 |
A J Hyde1, R Nassabein2, A AlShareef1, D Armstrong3, S Babak1, S Berry1, D Bossé1, E Chen1, B Colwell4, C Essery5, R Goel1, R Goodwin1, S Gray6, N Hammad1, A Jeyakuymar4, D Jonker1, P Karanicolas1, N Lamond4, R Letourneau2, J Michael6, N Patil4, E Powell3, R Ramjeesingh4, W Saliba4, R Singh4, S Snow4, T Stuckless3, S Tadros1, M Tehfé2, M Thana4, M Thirlwell2, M Vickers1, K Virik1, S Welch1, T Asmis1.
Abstract
The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference was held in Halifax, Nova Scotia, 20-22 September 2018. Experts in radiation oncology, medical oncology, surgical oncology, and pathology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of pancreatic cancer, pancreatic neuroendocrine tumours, hepatocellular cancer, and rectal and colon cancer, including ■ surgical management of pancreatic adenocarcinoma,■ adjuvant and metastatic systemic therapy options in pancreatic adenocarcinoma,■ the role of radiotherapy in the management of pancreatic adenocarcinoma,■ systemic therapy in pancreatic neuroendocrine tumours,■ updates in systemic therapy for patients with advanced hepatocellular carcinoma,■ optimum duration of adjuvant systemic therapy for colorectal cancer, and■ sequence of therapy in oligometastatic colorectal cancer. 2019 Multimed Inc.Entities:
Keywords: Guidelines; chemotherapy; colorectal cancer; hepatocellular carcinoma; pancreatic cancer; pancreatic neuroendocrine tumours; radiation therapy; surgery
Year: 2019 PMID： 31708660 PMCID： PMC6821113 DOI： 10.3747/co.26.5193
Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677